… -host disease treated by extracorporeal photochemotherapy: a retrospective study according
to … Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous …

… Extracorporeal photopheresis (ECP) also known as extracorporeal photochemotherapy or
extracorporeal phototherapy, involves repeated exposure of peripheral blood lymphocytes to …

… Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

… The objective of this meta-analysis (MA) was to evaluate the clinical efficacy and safety of
extracorporeal photopheresis (ECP) for the treatment of steroid-refractory chronic graft-versus-…

… Meta-analyses were carried out to calculate the overall … and were selected in this meta-analysis.
In patients with cGVHD, … with other meta-analyses, our meta-analysis included the most …

… After the first investigational study on the use of extracorporeal photopheresis for the treatment
of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by …

… Extracorporeal photopheresis (ECP) was initially developed for use in cutaneous T-cell
lymphoma (CTCL), and is now available at more than 200 centers worldwide. After the …

… The available body of evidence for the use of extracorporeal photopheresis (ECP) in children
and adolescents with acute graft‐versus‐host disease (GvHD) after haematopoietic stem …

… analysis according to disease manifestation will help to clarify this issue. If the value of
extracorporeal photopheresis … the various extracorporeal photopheresis regimens should follow. …

… Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy,
involves ex vivo exposure of mononuclear cells obtained by apheresis to a photosensitizing …